Patent: 10,563,224
✉ Email this page to a colleague
Summary for Patent: 10,563,224
Title: | Replication defective adenovirus vector in vaccination |
Abstract: | Methods for generating immune responses using adenovirus vectors that allow multiple vaccinations with the same adenovirus vector and vaccinations in individuals with preexisting immunity to adenovirus are provided. |
Inventor(s): | Jones; Frank R. (Seattle, WA), Gabitzsch; Elizabeth (Seattle, WA) |
Assignee: | Etubics Corporation (Seattle, WA) |
Application Number: | 15/433,934 |
Patent Claims: | see list of patent claims |
Details for Patent 10,563,224
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Amgen, Inc. | VECTIBIX | panitumumab | Injection | 125147 | 09/27/2006 | ⤷ Try a Trial | 2032-08-24 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |